Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 20, 2025Open Access

Targeting Inflammatory Cytokines in Autoimmune Diseases: Mechanisms and Therapeutic Advances with Antibody-Based Therapies

View Full Paper
Ask AI
Bookmark
Share

Authors

XZXiaolei ZhouJLJun LiangLJLongguang Jiang

Discussion

Loading...

Member takes

Overview

This review demonstrates therapeutic advances in targeting cytokines in autoimmune diseases, highlighting immunomodulation implications.

Key Points

  • Therapeutic antibody strategies effectively improve outcomes in autoimmune diseases, indicating a shift in treatment paradigms.
  • Clinically approved biologics, such as TNF inhibitors and IL-6R blockers, yield strong efficacy against autoimmune conditions.
  • Emerging therapies like bispecific antibodies enhance therapeutic precision, potentially transforming autoimmune disease management.
  • Personalized immunomodulation aims to significantly improve treatment outcomes for difficult-to-treat autoimmune diseases.

Cite This Study

Zhou et al. (2025) studied this question.

synapsesocial.com/papers/68d469d631b076d99fa66defhttps://doi.org/10.53941/hm.2025.100031
View Full Paper
Ask AI
Bookmark
Share